Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This phase 2, randomized, active-controlled, open-label, parallel group, multicenter study
will be conducted at up to 18 study centers in the US, Central America, and South America.
Adult subjects with metastatic colorectal cancer (CRC) who failed first-line chemotherapy
will participate in the study, which will be conducted on an outpatient basis. It is
anticipated that 100 subjects will be enrolled to obtain approximately 90 evaluable subjects.